<DOC>
	<DOCNO>NCT00528905</DOCNO>
	<brief_summary>The purpose study demonstrate AZD3480 improve cognition patient stable schizophrenia treat atypical antipsychotic active cigarette smoker , assess safety tolerability AZD3480 define optimal dose ( ) use future trial .</brief_summary>
	<brief_title>Proof Concept Study Cognitive Improvement Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Diagnosis schizophrenia Outpatient time screen randomization Stable housing define place live community ( ie , hospital nursing home ) Active cigarette smoking ( 10 cigarette per day Any significant psychiatric neurological disease schizophrenia , current diagnosis major depressive disorder Known suspect drug alcohol abuse within 6 month urine toxicology test positive illegal nonprescribed substance Impaired vision and/or hear make cognitive testing difficult</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Cognitive Deficits</keyword>
</DOC>